Medifast, Inc (MED): Price-to-Revenue Coefficient

Symbol and logo of brand OPTAVIA (MED)

Medifast, Inc. (MED) relies on B2C sales of nutrition plans, although the company is currently rebranding its image due to the expansion of new weight-loss drugs. The cost-to-sales ratio reflects current dynamics, where the parameter value equals 0.50. The business is influenced by moderate cyclicality and pronounced demand in the first quarter, when users return to a healthy lifestyle en masse.

MED - medifastinc.com Market Cap to Revenue over the range 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for OPTAVIA (MED)

- stock value and consensus price forecast:
General company analysis:MED (medifastinc.com)
Core merchandise of medifastinc.com

Customer loyalty to Medifast, Inc. (MED) weight loss programs directly impacts market capitalization, as reflected in the enterprise value-to-revenue ratio. This metric, calculated as the ratio of business value to total revenue, allows investors to assess the efficiency of brand monetization, while critically low values may signal a systemic crisis rather than an undervalued asset.